IRCT20180513039637N1已完成未知
Study of the effect of a session of endurance activity on the serum concentration of CC16 and SP-D in endurance elite runners and recreational runners
Tehran University0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 30 years（—）
- 性别
- Male
入选标准
- •Two years of championship experience in the province and country
- •Non-smoker and healthy
- •With no history of pulmonary disease and other clinical conditions
排除标准
- •Miscarriages
- •Heart disease and pulmonary disease
- •Being a smoker
研究者
相似试验
进行中（未招募）
不适用
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444.EUCTR2010-023444-32-DKGlaxoSmithKline341
进行中（未招募）
不适用
A study to evaluate lung treatment and exercise tolerance of COPD patients with a new bronchodilator: GSK573719/GW642444EUCTR2010-023442-75-EEGlaxoSmithKline341
进行中（未招募）
不适用
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444 - N/AEUCTR2010-023442-75-DEGlaxoSmithKline341
进行中（未招募）
不适用
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444. - n/aChronic Obstructive Pulmonary Disease (COPD)MedDRA version: 13.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-023444-32-GBGlaxoSmithKline341
进行中（未招募）
不适用
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444.EUCTR2010-023444-32-CZGlaxoSmithKline341